Change of Clinical Effect upon Use of Glutamine to Critically Ill Patients over Age 60 Receiving TPN

정맥영양 투여 받는 60세 이상 중환자에서 glutamine 사용에 따른 임상 효과의 변화

  • Received : 2014.02.15
  • Accepted : 2014.03.19
  • Published : 2014.03.31

Abstract

Background: It is known to reduce the mortality when glutamine is supplied to patients during the surgery or in intensive care unit through intravenous nutrition supply. The purpose of this study is to establish the appropriate basis for use of glutamine and guidelines of nutrition supply for critically ill patients in the hospital by examining the clinical effects of administration of glutamine with subjects of elderly critically ill patients receiving intravenous nutrition in one hospital in Korea. Method: Among elderly patients with age of 60 or more hospitalized in Yeuido St. Mary's Hospital from August 2012 to July 2013, those who stayed in the intensive care unit for more than a week and received TPN (Total Parenteral Nutrition) for more than 3 days during staying in the intensive care unit were classified to a test group using glutamine and a control group without glutamine. Duration of use of mechanical ventilator, duration of hospitalization, occurrence of infectious disease and death were compared between two groups. We would like to identify the clinical test figures affected by the use of glutamine by examining changes in SCr, Total Protein, Albumin, AST, ALT, TB, DB and GFR at the time of admission and discharge. Results: At the time of admission to intensive care unit, gender, physical measurement information and clinical test figures did not show any significant difference between 72 subjects in a test group and 24 subjects in a control group. Thus, two groups began in the same condition. There were no significant difference in duration of hospitalization, duration of intensive care unit, use of mechanical ventilator, occurrence of infectious disease and death. As the results of statistical analysis of the average changes of clinical test figures at the time of admission and discharge of intensive care unit, SCr and GFR were significantly changed in the test group. GFR was significantly changed in a control group. As the result of analysis of the clinical test figures at the time of discharge with reflection of average changes after clinical test figures were corrected at the time of admission of intensive care unit, TB and GFR were significantly increased in a test group compared with those in a control group. Other clinical test figures were not significantly changed. Conclusion: If glutamine is administered to critically ill patients over age 60 receiving TPN and careful monitoring for total bilirubin is made in the future, it is expected to give the positive effect on renal function andminimize the side effect of arise in total bilirubin.

Keywords

References

  1. Kondrup J, Rasmussen HH, Hamberg O, et al. Ad Hoc ESPEN Working Group. Nutritional rsik screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr 2003; 22(3): 321-36. https://doi.org/10.1016/S0261-5614(02)00214-5
  2. Yen PK. Medical nutrition therapy saves money. Geriatr Nurs 1996; 17(6): 293-4. https://doi.org/10.1016/S0197-4572(96)80245-X
  3. Weinsier RL, Hunker EM, Krumdieck CL, et al. Hospital malnutrition. A prospective evaluation of general medical patients during the course of hospitalization. Am J Clin Nutr 1979; 32(2): 418-26.
  4. Kang JH, Baek HW, Shin DW, et al. The Outcomes of Critically Ill Patients after Following the Recommendations of the Nutritional Support Team. KJPEN 2010; 3(1): 40-44.
  5. Gottschlich MM, Matarese LE, Shronts EP. Nutritional Support Dietetics. Core curriculum. 2NDed. SliverSprings: ASPEN; 1993.
  6. Matarese LE, Gottschlich MM. Contemporary nutrition Support Practice. A clinical guide. 2NDed. Saunders; 2003.
  7. Dock-Nascimento DB, Tavares VM, de Aguilar-Nascimento JE. Evolution of nutritional therapy prescription in critically ill patients. Nutr Hosp 2005; 20(5): 343-7.
  8. Qui Y, Zhu X, Wang W, et al. Nutrition support with glutamine dipeptide in patients undergoing liver transplantation. Transplant Proc 2009; 41(10): 4232-7. https://doi.org/10.1016/j.transproceed.2009.08.076
  9. Heyland DK, Dhaliwal R, Drover JW, et al. Canadian Critical Care Clinical Practice Guidelines Committee. Canadian clinical practice guideline for nutrition support in mechanically ventilated, critically ill adult patients. J Parenter Enteral Nutr 2003; 27(5): 355-73. https://doi.org/10.1177/0148607103027005355
  10. Jiang JW, Ren ZG, Chen LY, et al. Enteral supplementation with glycyl-glutamine improves intestinal barrier function after liver transplantation in rats. Hepatobiliary Pancreat Dis Int 2011; 10(4): 380-5. https://doi.org/10.1016/S1499-3872(11)60064-7
  11. Vanek VW, Matarese LE, Robinson M, et al. Novel Nutrient Task Force, Parenteral Glutamine Workgroup; American Society for Parenteral and Enteral Nutrition (A.S.P.E.N) Board of Directors. A.S.P.E.N position paper: parenteral nutrition glutamine supplementation. Nutr Clin Pract 2011; 26(4): 479-94. https://doi.org/10.1177/0884533611410975
  12. Jones NE, Heyland DK. Pharmaconutrition: a new emerging paradigm. Curr Opin Gastroenterol 2008; 24(2): 190-7. https://doi.org/10.1097/MOG.0b013e3282f4db94
  13. Jang CH. Evidence based nutrition therapy in ICU. 6th Congress of the Korean Society for parenteral and Enteral Nutrition 2007; 49-51.
  14. Behara AS, Peterson SJ, Chen Y, et al. Nutrition support in the critically ill: a physician survey. J Parenter Enteral Nutr 2008; 32(2): 113-9. https://doi.org/10.1177/0148607108314763
  15. http://health.naver.com/medical
  16. Zhang Y, Zou Z, Li YK, et al. Glutamine-induced heat shock protein protects against renal ischaemia-reperfusion injury in rats. Nephrology 2009; 14: 573-80. https://doi.org/10.1111/j.1440-1797.2009.01108.x
  17. Fuller TF, Rose F, Singleton KD, et al. Glutamine donor pretreatment in rat kidney transplants with severe preservation reperfusion injury. J Surg Res 2007; 140: 77-83. https://doi.org/10.1016/j.jss.2006.10.021
  18. Hwang JK. The early-stage renal protective effect on the rat's renal ischemic-reperfusive damages after ischemic pretreatment and glutamine administration. In: Master's degree thesis, College of Medicine.The Catholic University of Korea, 2011.
  19. Wagner WH, Lowry AC. Silberman H. Similar liver function abnormalities occur in patients receiving glucosebased and lipid based parenteral nutrition. Am J Gasreoenteral 1983; 78: 199-202.
  20. Kim IH. The Evaluation of Liver Function on Cancer Patients Depending on the Total Calorie of TPN. In: Master's degree thesis, Graduate School of Clinical Pharmacy, Sookmyung Women's University, 2006.